Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression

D

Diskapi Teaching and Research Hospital

Status and phase

Unknown
Phase 4

Conditions

Bladder Cancer

Treatments

Procedure: Transurethral Resection
Drug: Tamsulosin

Study type

Interventional

Funder types

Other

Identifiers

NCT02443844
16.02.2015 20/03

Details and patient eligibility

About

The purpose of this study is to compare medical and surgical treatments of benign prostate hyperplasia in patients who have non muscle invasive bladder cancer for tumour recurrence and progression.

Enrollment

40 estimated patients

Sex

Male

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who have non muscle invasive bladder cancer male patients patients between 40-80 years old

Exclusion criteria

  • Patients who have previous prostate surgery Patients who have muscle invasive bladder cancer

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

First group
Active Comparator group
Description:
Patients taken tamsulosin for benign prostate hyperplasia who have non muscle invasive bladder cancer
Treatment:
Drug: Tamsulosin
Second Group
Active Comparator group
Description:
Patients taken transurethral resection prostatectomy for benign prostate hyperplasia who have non muscle invasive bladder cancer
Treatment:
Procedure: Transurethral Resection

Trial contacts and locations

1

Loading...

Central trial contact

Nihat Karakoyunlu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems